Assess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes
Clinical trial NCT04365400 · TERMINATED
Trial details
- NCT number
- NCT04365400
- Sponsor
- Afimmune
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-13
- Primary completion
- 2022-05-03
- Enrollment
- 233
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.